Key result
Administration of of tPA via EKOS catheters over 12 hours resulted in improvement of right ventricular size and function in a patient with extensive bilateral pulmonary emboli.
Why the study?
Does catheter-directed tPA via EKOS catheter improve right ventricular size and function in a patient with extensive bilateral pulmonary emboli?
Case Report (n=1)
Does catheter-directed tPA via EKOS catheter improve right ventricular size and function in a patient with extensive bilateral pulmonary emboli?
Catheter-directed tPA via EKOS catheters successfully improved right ventricular size and function in a patient with extensive pulmonary embolism and high bleeding risk due to a recent stroke.
Answers are grounded in this paper and cite their sources.
Single-case RV improvement with EKOS tPA in PE; hypothesis-generating and leaves open comparative safety/efficacy versus standard care.
A 69-year old bed-bound woman presented with chest pain and diaphoresis. Diagnostic imaging led to the diagnosis of bilateral extensive pulmonary emboli extending into all segmental branches. Tissue plasminogen activator (tPA) was administered via 2 separate EKOS catheters. Repeat evaluation after 33 hours revealed improvement of right ventricular size and function. EKOS catheters are useful for administration of fibrinolytics in pulmonary embolism.
No takes yet. Share an insight, caveat, or question.
Veean et al. (2017) conducted a case report in Pulmonary embolism (n=1). tPA via EKOS catheter was evaluated on Right ventricular size and function. Administration of of tPA via EKOS catheters over 12 hours resulted in improvement of right ventricular size and function in a patient with extensive bilateral pulmonary emboli.
Synapse has enriched 10 related papers. Consider them for comparative context: